Search Results for: infliximab

February 1, 2021February 1, 2021

Bacterial, Fungal Profiles Predict Infliximab Response, Study Reveals

Crohn's Disease, IBD News, News, Ulcerative colitis

Bacterial and fungal profiles found in fecal samples from people with inflammatory bowel disease (IBD) were able to predict the patients’ responses to the anti-inflammatory therapy infliximab, a study revealed. ... Read more

March 23, 2020March 23, 2020

Infliximab Helps Gut Microbiome in Children with Crohn’s, Study Finds

News

Treatment with infliximab helps normalize the gut microbiome, soothing Crohn’s disease in children and adolescents, a study suggests. Longer studies are needed to understand if these medicines can fully restore ... Read more

Ixifi (Infliximab-qbtx)

Ixifi (infliximab-qbtx) is an approved treatment for the inflammatory bowel diseases Crohn’s and ulcerative colitis. Pfizer developed it as a biosimilar to Remicade (infliximab) after Remicade’s patent protection ran out. A biosimilar ... Read more

June 9, 2016August 12, 2016

IBD Study Shows Celltrion’s Inflectra, Biosimilar of Infliximab, Is Safe and Effective

Crohn's Disease, IBD News, News, Ulcerative colitis

Celltrion’s Inflectra, a biosimilar version of infliximab (Remicade), is both safe and effective in patients with inflammatory bowel disease (IBD), a recent study reported at the Digestive Disease Week 2016 meeting ... Read more

November 6, 2015November 11, 2015

Biosimilar Infliximab IBD Drug Shown to Be as Effective and Safe as Original Therapy

News

Celltrion Healthcare recently presented positive clinical results of recent studies evaluating the efficacy and safety of switching from the original infliximab therapy (RMP) to the biosimilar infliximab Remsima® treatment in patients with ... Read more

August 17, 2015August 17, 2015

MSD Releases Statement on NICE Publication HTTA329 on Introducing Biosimilars of Infliximab

IBD News, News

Last July 2015, NICE published HTTA329 as a reference for select NHS organizations in the UK that are currently planning to join the market with their own biosimilar products for ... Read more

June 8, 2015June 8, 2015

First Infliximab Biosimilar Approved in Brazil For Crohn’s Disease

Crohn's Disease, News

The National Health Surveillance Agency (ANVISA) in Brazil has approved the commercialization of Remsima (infliximab), indicated for a series of conditions such as Crohn’s disease and ulcerative colitis, making it the first ... Read more

May 22, 2015May 22, 2015

Safety and Efficacy of Biosimilar Infliximab Treatment in IBD Patients Presented at DDW 2015

IBD News, News

Celltrion Healthcare and Jørgen Jahnsen, Professor of Gastroenterology at the University of Oslo in Norway recently presented at the Digestive Diseases Week (DDW) 2015 in Washington D.C. results from a study ... Read more